Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
Azar Testifies on President Trump’s FY 2020 Budget
On March 13, 2019, Health and Human Services (HHS) Secretary Alex Azar testified on President Donald Trump’s proposed 2020 budget…
House Subcommittee Holds Fiery Hearing on Generic Competition
On Wednesday, March 13, 2019, the House Energy and Commerce Subcommittee on Health held a hearing to discuss a slate of bills, all…
Congress Seeks Information from FDA on Powerful Opioid
Drug pricing and opioids have remained front and center as the 116th Congress got sworn in and started hosting hearings and…
Senate Appropriations Subcommittee Holds Hearing on Federal Funding Used by…
On Thursday, February 28, 2019, the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related…
Industry CEOs Testify at Senate Finance Hearing
On Tuesday, February 26, 2019, the Senate Finance Committee held a hearing on drug costs and potential policy solutions to bring…
Is Divided Government Bad for Pharma?
Reasonable people may disagree about whether our currently divided government is a good thing or a bad thing, especially as it…
Bipartisan Legislation Drafted on New Payment Models
Senators Bill Cassidy, a Republican from Louisiana, and Mark Warner, a Democrat from Virginia, have teamed up and are seeking…
Aggressive Drug Pricing Proposals Introduced in Congress
As drug prices continue to be a hot news subject, legislative proposals to stymie the climb to higher prices are sure to be…
Reducing Drug Prices at the Top of Legislative Priority Lists
With the new United States Congress now sworn in and Committee assignments solidified, different priorities are starting to become…
Medicaid Drug Decisions Transparency Act: Last Minute Bill to be Introduced…
Better late than never? During this last week of session for the United States Congress, Senator Cory Booker of New Jersey plans…